Spontaneous generation of infectious nucleating amyloids in the transmissible and nontransmissible cerebral amyloidoses
Abstract
The unconventional viruses of the transmissible subacute spongiform encephalopathies (kuru-CJD-GSS-FFI-scrapie-BSE) are nucleants spontaneously generated from host precursor proteins altered to beta-pleated sheet configuration that polymerize into insoluble infectious amyloid fibrils. The de novo conversion to infectious amyloids is facilitated or accelerated by many different point mutations causing amino acid changes, a stop codon, or octapeptide inserts that increase the likelihood of spontaneous conversion to infectious configuration by many orders of magnitude. Similar nucleating induction of configurational change to amyloid probably occurs in other amyloidoses of brain and in systemic amyloidoses. Thus, all amyloids, particularly so-called fibrillar amyloid enhancing factors, may be considered to be infectious scrapie-like agents. These events probably occur extracellularly, thus we are attempting to reproduce them in vitro, even from synthetic polypeptides.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Pathologic similarities with prion disease suggest that the formation and spread of proteinaceous lesions might involve a common molecular mechanism, corruptive protein templating.
“Pathologic similarities with prion disease suggest that the formation and spread of these proteinaceous lesions might involve a common molecular mechanism – corruptive protein templating.”
From Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders (2011) · cites this paper as [3]
The citation lists haven’t been fetched yet
References 62 · Cited by 60
- Authors
- Gajdusek, D. C.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Gajdusek, D. Carleton
- Venue
- Molecular Neurobiology
- Published
- 1994-02
- Volume
- 8
- Issue
- 1
- Pages
- 1-13
- ISSN
- 0893-7648 (ISSN-L)
- 1559-1182
- OpenAlex
- W2021561354
- Cited by
- 60
- References
- 62
- Citations by year
- 2025: 1 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 1 · 2013: 3 · 2012: 3
- FWCI
- 0.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Molecular Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Amyloidosis: Diagnosis, Treatment, Outcomes
- Keywords
- prion disease, prions, kuru, Creutzfeldt-Jakob disease, fatal familial insomnia, scrapie, bovine spongiform encephalopathy, point mutations, synthetic polypeptides
- MeSH terms
- Alzheimer Disease, Amyloid, Amyloidosis, DNA Mutational Analysis, Ethnicity, Genes, Humans, Polymers, Prealbumin, Protein Processing, Post-Translational, Global Health, Incidence, Amyloid beta-Protein Precursor, Prion Diseases, Point Mutation, Protein Structure, Secondary, Protein Folding, Amyloid Neuropathies, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review